Relacorilant

Overview

Relacorilant is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4068611).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Relacorilant expires 22 Dec 2041 and exclusivity 25 Mar 2031. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

[(4aR)-1-(4-fluorophenyl)-6-(1-methylpyrazol-4-yl)sulfonyl-4,5,7,8-tetrahydropyrazolo[5,4-g]isoquinolin-4a-yl]-[4-(trifluoromethyl)-2-pyridinyl]methanone

Canonical SMILES

CN1C=C(C=N1)S(=O)(=O)N2CCC3=CC4=C(C[C@@]3(C2)C(=O)C5=NC=CC(=C5)C(F)(F)F)C=NN4C6=CC=C(C=C6)F

InChIKey

WANIDIGFXJFFEL-SANMLTNESA-N